Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis.

Saved in:
Bibliographic Details
Title: Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis.
Authors: Onda, Yoshiyuki, Kanda, Junya, Kaneko, Hitomi, Shimura, Yuji, Fuchida, Shin-ichi, Nakaya, Aya, Itou, Tomoki, Yamamura, Ryosuke, Tanaka, Hirokazu, Shibayama, Hirohiko, Shimazu, Yutaka, Uchiyama, Hitoji, Yoshihara, Satoshi, Adachi, Yoko, Matsuda, Mitsuhiro, Hanamoto, Hitoshi, Uoshima, Nobuhiko, Kosugi, Satoru, Ohta, Kensuke, Yagi, Hideo, et al
Source: Therapeutic advances in hematology 6/24/2022; Vol. 13.
Journal Info: Publisher: Sage Publications Inc. ISSN: 2040-6207
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2040-6215
DOI:10.1177/20406207221104584